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Purpose:  The  aim  of  this  study  was  to  systematically  compare  organ-speciﬁc-radiation  dose  levels
between  a radiation  dose  optimized  perfusion  CT  (dVPCT)  protocol  of the  liver  and  a tri-phasic  standard
CT  protocol  of the  liver  using  a Monte-Carlo-Simulation-based  analysis  platform.
Methods  and  materials:  The  complete  CT data  of  52  patients  (41  males;  mean  age  65  ± 12)  with  suspected
HCC  that underwent  dVPCT  examinations  on a 3rd  generation  dual-source  CT  (Somatom  Force,  Siemens)
with a dose  optimized  tube  voltage  of  70 kVp  or 80 kVp  were  exported  to an  analysis  platform  (Radimet-
rics,  Bayer).  The  dVPCT  studies  were  matched  with  a reference  group  of  50 patients  (35 males;  mean  age
65  ± 14)  that  underwent  standard  tri-phasic  CT (sCT)  examinations  of  the  liver with  130  kVp  using  the
calculated  water-equivalent-diameter  of  the  patients.  The  analysis  platform  was  used for the  calculation
of  the  organ-speciﬁc  effective  dose  (ED)  as  well  as  global  radiation-dose  parameters  (ICRP103).
Results:  The  organ-speciﬁc  ED  of the  dVPCT  protocol  was  statistically  signiﬁcantly  lower  when  compared
to  the  sCT  in  14 of 21,  and noninferior  in a total  of  18  of 21  examined  items  (all  p <  0.05).  The  EDs  of  the
dVPCT  examinations  were  especially  in the  dose  sensitive  organs  such  as the red  marrow  (17.3 mSv  vs
24.6 mSv,  p  =  <  0.0001)  and  the  liver (33.3  mSv  vs  46.9  mSv,  p =  0.0003)  lower  when  compared  to the  sCT.
Conclusion:  Our  results  suggest  that dVPCT  performed  at 70 or  80 kVp  compares  favorably  to sCT per-
formed  with  130  kVp  with  regard  to effective  organ  dose  levels,  especially  in  dose  sensitive  organs,  while
providing  additional  functional  information  which  is  of paramount  importance  in patients  undergoing
novel  targeted  therapies.
©  2016  The  Authors.  Published  by  Elsevier  Ltd. This  is an  open  access  article  under  the CC  BY-NC-ND. Introduction
Tri-phasic contrast-enhanced abdominal computed tomogra-
hy (CT) is the standard CT technique in patients with known or
uspected hepatocellular carcinoma (HCC). However, optimal late
rterial enhancement in patients with suspected HCC is often cru-
ial leading to a suboptimal depiction of hypervascularized HCC
esions.
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Dynamic volume perfusion-CT (dVPCT) is a rapidly develop-
ing technique, which allows the acquisition of morphological and
functional perfusion information. In contrast to standard tri-phasic
contrast-enhanced CT (sCT), dVPCT is based on the measurement of
the temporal distribution of intra-venously injected contrast mate-
rial by repeated scanning of the tissue of interest [1]. Functional
dVPCT parameters provide several beneﬁts within the context
of oncological imaging. Faivre S et al. demonstrated that dVPCT
parameters a more appropriate for response evaluation in patients
with HCC undergoing sunitinib therapy when compared to RECIST
[2]. In addition, several studies have demonstrated that dVPCT is
a useful imaging biomarker in patients with HCC undergoing min-
imally invasive therapies like transarterial chemoembolization or
transarterial radioembolization [3,4]. Besides advanced response
evaluation, improved detection of hypervascular liver lesions [5]
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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Table 1
Patient collectives.
liver dVPCT protocol triphaseal sCT
n 52 50♂/♀ 41/11 35/15
age  ∅ 65 65
WED  ∅ [mm] 307 307
CTDI ∅ [mGy] 23 11,89
DLP ∅ [mGy*cm] 1931 1936
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ED: Water equivalent diameter, DLP: Dosis length product.
s well as differentiation between hemangioma and hypovascular
etastases has also been demonstrated for dVPCT [6,7].
However, despite the above mentioned beneﬁts, dVPCT has not
et found its way into clinical routine. This is mainly due to con-
erns about high radiation dose levels and limited dynamic z-axis
overage with previous CT generation. Recently introduced state-
f-the-art CT systems have enabled dVPCT studies performed with
0–80 kVp tube voltage covering whole anatomic regions or organs
ike the liver. The reduced tube voltage in dVPCT studies has the
dvantage to signiﬁcantly reduce radiation dose levels while at
he same time increasing contrast attenuation. However, low kVp
VPCT protocols potentially reduce radiation dose levels, there is
till a lack of a detailed radiation dose evaluation of low kVp dVPCT
rotocols [8].
Thus, the aim of this study is to systematically evaluate organ
peciﬁc radiation doses of a 70/80 kVp dVPCT liver protocol in
atients with suspected HCC in comparison to a tri-phasic sCT pro-
ocol.
. Materials and methods
.1. Study design
This retrospective HIPAA compliant single-center study was
pproved by the institutional review board and complies with the
eclaration of Helsinki. The analyzed datasets were acquired in the
linical routine and retrospectively matched. All dVPCT patients
nderwent the examination due to suspected or known HCC. To
inimize body shape related radiation dose differences the com-
arison group that underwent a tri-phasic sCT protocol of the
pper abdomen was retrospectively matched via the water equiv-
lent diameter (WED) with the dVPCT protocol group (Table 1) [9].
esides the organ speciﬁc dose analysis of the liver dVPCT and the
omparison to the tri-phasic abdomen protocol, the dose values of
he 70 and 80 kVp dVPCT protocols were compared to each other.
.2. Patient characteristics
The liver dVPCT group consisted of 52 patients (41 males, mean
ge 65 ± 12.8 [range 33–92]) with suspected HCC. The reference
CT group that served for the radiation dose comparison consisted
f 50 patients (35 males, mean age 65 ± 14 [range 20–87]) that
nderwent a tri-phasic sCT of the liver due to various indications.
.3. CT protocols
.3.1. Dynamic volume perfusion CT protocol
All patients underwent an examination on a 3rd generation
ual-source CT system (Somatom FORCE, Siemens Healthcare Sec-
or, Forchheim, Germany) using the following scan paramaters:
0 or 80 kVp tube voltage (80 kVp in patients with an body
ass index >33), 189 mAs  tube current time-product at 70 kVp;
20 mAs  tube current time-product at 80 kVp, 48 × 1.2 collimation,
-dimensional spiral mode with variable pitch with a z-axis cover-Fig. 1. automated matching of scanned CT images and digital pa5ent phantom.
age of 22.4 cm.  In all patients 18 spiral acquisitions were performed
with a variable interscan delay (2 × 3 s; 10 × 1.5 s; 3 × 6 s; 2 × 15 s;
1 × 18 s) resulting in a total acquisition time of 71.2 s. The ﬁrst
acquisition was  started 10 s after the start of the contrast injec-
tion. For contrast injection, 50 mL of nonionic iodinated contrast
medium (Iomeprol 400, Bracco Imaging S.p.A., Milan, Italy) were
injected through an 18-gauge needle in a cubital vein at a rate
of 5 cc/s using a power injector (Stellant® D CT Injection System
MEDRAD, Inc., Warrendale, USA) followed by a 50 mL  saline chaser
injected at the same ﬂow rate. All patients were instructed to hold
their breath as long as possible in a mid-exhalation state. If breath
hold was  not possible anymore throughout the scan, patients were
instructed to shallow breath only through their nose in order to
minimize motion. The raw data of dVPCT were reconstructed using
a medium sharp convolution kernel (Br 36) at a slice thickness
of 1.5 mm and a 1.3 mm increment using ﬁltered back projection
(FBP). The mean DLP of the dVPCT was  1931 ± 565 mGy*cm.
2.3.2. Tri-phasic standard CT protocol
All patients of the reference sCT group underwent an tri-phasic
CT of the upper abdomen on a clinical routine scanner (Somatom
Emotion, Siemens Healthcare, Forchheim, Germany) using the fol-
lowing scanning parameters: 130 kVp tube voltage; 110 reference
mAs tube current time product using automated tube current mod-
ulation (CareDose4D, Siemens Healthcare, Forchheim, Germany);
16 × 1.2 detector collimation, 0.8 pitch factor. All images were
reconstructed using FBP with a slice thickness of 1.5 mm  using a
reconstruction increment of 1.3 mm and a soft tissue reconstruc-
tion kernel (B30s, Siemens Healthcare, Forchheim, Germany). After
the non-contrast enhanced acquisition the arterial phase was per-
formed with 80 cc of iodinated contrast material (Iomeprol 400,
Bracco Imaging S.p.A., Milan, Italy) injected with 4 cc/s via an ante-
cubital vein followed by a 50 mL  saline chaser injected at the same
ﬂow rate. For the determination of the scan start the bolus tracking
technique was  used with a ROI placed within the abdominal aorta
at the level directly below the diaphragm. After the trigger thresh-
old of 100HU was  reached the scan started after an additional scan
delay of 10 s. The portal-venous CT acquisition was started 70 s after
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erfusion exam is shown, on the right side the triphasic standard CT.
he start of the contrast administration. The mean DLP of the sCT
as 1936 ± 912 mGy*cm.
.4. Radiation dose calculation
A Monte-Carlo-Simulation-based analysis platform (Radimet-
ics, Bayer Healthcare, Germany) was used to calculate the organ
peciﬁc radiation dose values. Therefore the dVPCT and sCT datasets
ere uploaded to the capable, local analysis server. Afterwards
he software automatically matches the phantom and the patient
opogram (Fig. 1) and calculates the organ speciﬁc radiation dose
Fig. 2). Targets of the analysis were 17 individual organs (e.g. colon,
all bladder, red bone marrow etc.) as well as the global radiation
arameter ICRP103.
.5. Statistical analysis
The statistical analysis was performed using JMP 11 (SAS, Cary,
SA). A two-tailed t-test (CI 95%,  0.05) was performed to compare
he organ speciﬁc doses of the dVPCT protocol with the ones of
he sCT reference group as well as the doses of the 70 kV- with
he 80 kV-liver dVPCT group. Additionally a non-inferior analysis
as performed via an equivalent test, based on an one sided t-test.
he non-inferior margin, the border which deﬁnes the new method
dVPCT) as non-inferior to the old (sCT), was set at 5% of the mean
CT dose of the individual examined organ/radiation parameter. A
-value of <0.05 was in all test considered statistically signiﬁcant.
. Results
.1. Dynamic volume perfusion CT protocol
The mean DLP of the dVPCT protocol was 1931 mGy*cm
Table 1). The mean ICRP 103 was 22.6 mSv  (±6.5 mSv;
0.9–34.5 mSv). With 49.7 mSv, 40 mSv  and 38.4 mSv  the kidneys,
he gall bladder as well as the stomach were the organs with
he highest radiation dose exposure. The lowest organ speciﬁc
oses were calculated for the oesophagus (12 mSv) and the thymus
14.5 mSv). Radiation sensitive organs such as the colon and the red
arrow were affected by 34.9 mSv  respectively 17.3 mSv. Table 2
ummarizes all radiation dose parameters for the investigated 17
rgans in detail.ts with suspected hepatocellular carcinoma. On the left side, the dynamic volume
3.2. Comparison of radiation dose parameters between dynamic
volume perfusion CT and standard tri-phasic CT
The comparison between the dVPCT and the standard tri-phasic
CT has shown a signiﬁcant dose reduction not only in the ICRP
103 but also in 12 out of 17 examined organs. Especially radia-
tion sensitive organs like as the colon and the red bone marrow
showed statistically signiﬁcant lower organ dose values in the
dVPCT cohort when compared to the sCT patient cohort (colon:
34.9 mSv  dVPCT vs. 45.8 mSv  sCT, p = 0.0011; red marrow: 17.3 mSv
dVPCT: vs. 24.6 mSv  sCT; p < 0.0001). The organ dose values of the
heart, lungs, kidneys, skin and the thymus did not statistically dif-
fer between dVPCT and sCT acquisitions (p > 0.05). There was no
statistically signiﬁcant difference of the DLP between the matched
tri-phasic sCT examinations and the dVPCT acquisitions (tri-phasic
sCT: 1936 mGy*cm, SD = 912; dVPCT: 1931, SD = 565; p = 0.975)
either. The global radiation parameter ICRP 103 was found to be
statistically signiﬁcantly lower in the dVPCT acquisitions when
compared to the sCT acquisitions (dVPCT: 22.6 mSv, SD: 6.5; sCT:
31.7 mSv  sCT, SD: 13,3; p < 0.0001). A detailed explanation of our
results can be found in Table 2.
The non-inferiority analysis has shown a non-inferiority of the
dVPCT in 16 out of 17 examined organs (Table 2).
3.3. Comparison between 70 and 80 kVp vs. dynamic volume
perfusion CT radiation dose parameters
The comparison between the 70 kVp and 80 kVp dVPCT protocol
revealed lower radiation dose values in 13 of the 17 investi-
gated organs for the 70 kVp (Table 3) as well as in the ICRP 103.
Beneath this lower affected organs were the muscles, the red mar-
row, the skeleton, the skin and the urinary bladder. Nevertheless
only in 6 targets a signiﬁcant difference between the 70 kVp and
80 kVp protocol has been proven: ICRP 103 (21.4 mSv  vs. 26.37 mSv,
p = 0.013), muscle (18.2 mSv  vs. 26.1 mSv, p = < 0.0001), red mar-
row (16.1 mSv  vs. 20.3 mSv, p = 0.0027), skeleton (28.76 mSv  vs.
35.8 mSv, p = 0.0068), skin (21.59 mSv  vs. 32.14 mSv, p = < 0.0001)
and the urinary bladder (18.5 mSv  vs. 38.7 mSv, p = 0.0154). In all
examined targets, only the thymus has shown a lower organ spe-
ciﬁc dose in the 80 kV protocol (16.9 mSv  vs. 8 mSv; Table 3).
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Table 2
liver dVPCT protocol compared to the triphaseal sCT protocol.
means [mSv] standard deviation equivalence test two-tailed t-test
dVPCT sCT dVPCT sCT t-value p-value t-value p-value
adrenals 23.9 40 22 14.3 4.92 <0.0001 4.42 <0.0001
colon  34.9 45.8 20 13.9 4 <0.0001 3.36 0.0011
esophagus 12 16.4 10.7 9 2.66 0.0046 2.25 0.0267
gall  bladder 40.4 47.5 20 13.1 2.79 0.0031 2.1 0.0383
heart  18.3 24.2 20.2 17.6 1.89 0.0309 1.57 0.1192
ICRP103 22.6 31.7 6.6 13.3 5.12 <0.0001 4.3 <0.0001
kidneys 49.7 54.2 25.6 15 1.73 0.0431 1.09 0.2776
liver  33.3 46.9 20.9 15 4.4 <0.0001 3.79 0.0003
lungs  18.4 19.9 20.3 15.6 0.69 0.246 0.42 0.67
muscle 20.3 28 5.4 11.8 5.02 <0.0001 4.19 <0.0001
pancreas 23.9 39.4 17.2 12.6 5.82 <0.0001 5.2 <0.0001
red  marrow 17.3 24.6 3.7 9.4 6.04 <0.0001 5.09 <0.0001
skeleton 30.5 38.5 9.4 19.1 3.34 0.0006 2.66 0.0097
skin  22.4 28 6.5 13.2 2.4 0.0092 1.69 0.095
spleen 31.5 46.8 21.9 14.6 4.78 <0.0001 4.17 <0.0001
stomach 38.4 49.4 21.1 14.6 3.73 0.0002 3.07 0.0028
thymus 14.5 7.8 23.6 12.6 −1.68 0.95 −1.8 0.0754
urinary bladder 25.1 48.6 20.2 17.7 6.88 <0.0001 6.25 <0.0001
dVPCT: Dynamic volume perfusion CT, sCT: Standard CT.
Table 3
Statistical analysis of the 70kV- and 80kV-liver dVPCT protocols.
means [mSv] standard deviation two-tailed t-test
70 kV 80 kV 70 kV 80 kV t-value p-value
adrenals 22.86 27.85 22 24 0.63 0.5343
colon  30.85 43.1 17.8 23.8 1.6 0.12
esophagus 12.58 10.8 11.5 8.9 −0.5 0.58
gall  bladder 38 47.9 17 26 1.23 0.23
heart  19.237 16.8 21.65 17 −0.4 0.69
ICRP103 21.4 26.37 6.5 5.2 2.69 0.013
kidneys 46.7 58.8 22.2 31.9 1.23 0.2381
liver  31.49 39 20 23.8 0.9 0.33
lungs  19.9 15.27 22 14 −0.8 0.41
muscle 18.2 26.1 3.75 4.78 5.25 <0.0001
pancreas  22.7 27.49 17 18.6 0.7 0.4407
red  marrow 16.1 20.3 2.9 3.7 3.56 0.0027
skeleton 28.76 35.8 9.7 6.3 2.9 0.0068
skin  21.59 32.14 3.9 4.7 7 <0.0001
spleen  29.79 36.73 21 24.2 0.889 0.3862
stomach 36.3 45 19.6 24.5 1.1 0.2766
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. Discussion
Our study provides a systematically analysis of organ speciﬁc
adiation dose values associated with dVPCT performed with 70
r 80 kVp. In addition, we compared organ dose values between
VPCT and a triphasic sCT protocol. Our results demonstrate, that
VPCT with low tube voltage settings lead to non-inferior radia-
ion dose values when compared to sCT. Besides the fact, that the
LP of the dVPCT and the sCT did not statistically signiﬁcantly dif-
er our results show that in the majority of the examined organs
he speciﬁc organ dose values were signiﬁcantly lower in patients
ndergoing dVPCT at 70 or 80 kVp. Interestingly, the thymus was
he only investigated organ in which the sCT protocol has lead to a
ower organ speciﬁc radiation dose. The higher dose of the thymus
ould be explained by the shuttle-mode technique that was  used
or the dVPCT acquisitions. In this technique, the patients shuttles
ack and forth 18 times leading to a higher scatter radiation for
rgans outside of the scan ﬁeld.
The radiation dose reduction for all other organs can be is
xplained by various factors. First, the main inﬂuence is most likely
ttributed the tube voltage reduction (70 or 80 kVp vs. 130 kVp). As 6.7 −1.8 0.0699
.8 23.9 2.775 0.0154
shown in previous studies, a lower tube voltage leads to a signiﬁ-
cant reduction of the effective dose [8]. In the early development
of perfusion CT a reduced tube voltage of 70–80 kV has already
become the standard in order to minimize the total radiation dose
during continuous scanning [10]. However, with the introduction of
dVPCT over a larger z-axis the tube current of most clinically avail-
able CT systems was  not sufﬁcient in order to cover larger anatomic
areas with low tube voltage settings [1]. The reduced tube current
in combination with state of the art noise reduction algorithms and
full digital CT detectors that reduce electronic noise are also respon-
sible for the dose reduction of state-of-the-art dVPCT protocols [1].
It is of special importance, that iterative reconstruction techniques
are currently not available for the reconstruction of dVPCT raw data.
Therefore, one can expect that radiation dose reduction in dVPCT
will further evolve once iterative reconstruction techniques will
become available for dVPCT. The radiation dose values observed in
our study are in accordance to previous studies that reported mean
CTDIs of 12.4 mGy  for 16-slice CTs (11.89 ± 4.47 in our study) and
mean DLPs of 1831 mGy*cm for dVPCT (1931 ± 565 in our study)
[11,12]. In contrast to those studies we did not only focus on global
radiation parameters but also on organ speciﬁc radiation doses.
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thoraco-abdominal trauma CT—a comparison to ﬁxed kV with mAsJ. Gawlitza et al. / European Jour
Our study has several limitations which have to be con-
idered. First, we compared our dVPCT protocol with a sCT
rotocol on a 16 slice MDCT system equipped with automated
ube current modulation but no iterative reconstruction and not
utomated tube voltage selection. Therefore, one has to acknowl-
dge that our results are not necessarily representative for more
ecent CT systems with iterative reconstruction techniques as well
s automated tube voltage selection and full digital detectors for
ose reduction. However, 16-slice MDCT systems are still the most
idely used systems world-wide. Moreover, even if state-of-the-
rt CT systems may  lead to lower radiation dose levels when
ompared to our low tube voltage dVPCT our results indicate that
VPCT is not inevitably associated with higher radiation dose levels
hich is still the general perception of many radiologists. Within
his context, one has to deliberate about whether patient beneﬁt
rom additional functional information or whether the additional
adiation dose has harmful effects for the patient. Second, our study
opulation is relatively small and our results are not generally rep-
esentative for all dVPCT acquisition techniques. Since, wider CT
etectors are known to be less dose efﬁcient our results should only
e interpreted within the context of shuttle-mode dVPCT acquisi-
ions.
In conclusion, our study demonstrated that dVPCT of the liver
hows non-inferior radiation dose values when compared to a tri-
hasic sCT acquisition. Thus, dVPCT could be used more widely
n patients undergoing targeted therapies or minimally invasive
herapies like transarterial chemoembolization or transarterial
adioembolization.onﬂict of interest
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